Cme Slides Forum

CME SLIDES FORUM

Archive

	Who and how should we screen for CKD in the elderly population?		CKD originating in pregnancy and in childhood
Dr R. Gansevoort Department of Nephrology Unviersity Medical Center Groningen, The Netherland		Dr G. Filler Department of Paediatrics University of Western Ontario London, Canada

	Who and how to screen for CKD?		Early identification of CKD: the primary care physician-nephrologist interface
Dr S. Hallan Department of Cancer Research and Molecular Medicine Faculty of Medicine, Norwegian University of Science and Technology Trondheim, Norway		Dr P. Stevens Department of Renal Medicine Kent and Canterbury Hospital Canterbury, United Kingdom

	Human renal dysplasia syndromes: mixing cell biology and genetics
Prof A. Woolf Nephro-Urology Unit UCL Institute of Child Health London, United Kingdom

The incidence and prevalence of hyponatremia

Normal renal physiology in pregnancy

Prof A. Wiecek
Professor of Internal Medicine and Nephrology
Head of the Department of Nephrology, Endocrinology and Metabolic Diseases
Silesian University School of Medicine
Katowice, Poland

Prof J. Bernheim
Head of Department of Nephrology & Hypertension
Meir Medical Center
Kfar Saba, Israel

Pathophysiology of pre-eclampsia

Pre pregnancy counselling for women with CKD

Dr M. Hladunewich
Division of Nephrology
Department of Medicine
University of Toronto
Toronto, Canada

Dr L. Lightstone
Renal Section, Division of Medicine
Faculty of Medicine, Imperial College
Hammersmith Hospital
London, United Kingdom

	Klotho as a regulator of fibroblast growth factor signalling and phosphate/calcium metabolism		Treatment of uraemic patients with vitamin D receptor activators
Prof M. Kuro-o Department of Pathology The University of Texas Southwestern Medical Center at Dallas Dallas, TX, USA		Prof T.B. Drueke Inserm U507 and Service de Nephrologie Hôpital Necker Paris, France

	FGF-23 in CKD, Ectopic Calcification, Posttransplantation-Hypophosphatemia, and Nephrolitiasis
Dr. M. Fukagawa Division of Nephrology and Dialysis Center Kobe University School of Medicine Kobe, Japan

Trends in following European Best Practice Guidelines and outcomes

Advantages of facility-level analyses

Prof B. Canaud
Service de Nephrologie
Hopital Lapeyronie
Montpellier, France

Prof Robert A. Wolfe
Biostatistics Department
University of Michigan
School of Public Health
Ann Arbor, MI, USA

	Chronic kidney disease: a new public health problem		Renal phosphate handling: from cell physiology to modern integrative renal physiology
Prof. Andrew S. Levey Division of Nephrology Tufts University School of Medicine Boston, USA		Prof. Heini Murer Center for Integrative Human Physiology University of Zurich Zurich, Switzerland

	Bench to bedside educated investigators in Europe
Prof. M. De Broe Department of Nephrology University of Antwerp Antwerpen, Belgium

New frontiers in critical care Nephrology

	Energy and Protein Intake in critically ill patients with ARF		Insulin resistance in the critically ill patient. Prognostic and therapeutic implications
Dr E. Fiaccadori Internal Medicine and Nephrology Department University Medical School Parma, Italy		Dr. Talat A. Ikizler Division of Nephrology Vanderbilt University, Medical Centre Nashville, USA

	Extended daily dialysis for treatment of ARF in the ICU		Gene therapy in the treatment of acute renal failure
Dr. Jan T. Kielstein Department of Nephrology Medical School Hannover Hannover, Germany		Prof. Jospep M. Grinyo Experimental Nephrology Laboratory University of Barcelona, Campus Bellvitge Barcelona, Spain

	Basic physiology is the salt for PD treatment		Residual renal function and the epidemiology of volume overload and hypertension in peritoneal dialysis
Dr W. van Biesen Dept of Nephrology University Hospital Ghent Ghent, Belgium		Prof. R. Krediet Chief Division of Nephrology Academic Medical Centre Amsterdam, The Netherlands

	Fluid balance, nocturnal PD and sleep apnea
Dr S.C.W. Tang The University of Hong Kong Queen Mary Hospital Hong Kong, China

Is brachial arterial pressure the best way to assess cardiovascular structural damage? An overview and lessons from clinical trials

Arterial rigidity and the kidney

Prof G. London
Department of Nephrology
Manhes Hospital
Fleury-Merogis, France

Prof J. Blacher
Hypertension Unit
Hôtel-Dieu, université Paris–Descartes
Paris, France

Alterations of arterial rigidity in children and adolescents. End stage renal disease and beyond

Prof Adrian Covic
Full Professor of Nephrology
Dialysis and Renal Transplantation Unit
“C. I. Parhon” University Hospital
Iasi, Romania

Salt intake, hypertension and cardiovascular diseases. Will the dilemma be ever solved?

Sodium storage and BP control: a novel component controlling the salt-BP relationship

Prof Eberhard Ritz
Dept. Internal Medicine
Division Nephrology
Heidelberg, Germany

Dr Jens Titze
Department of Nephrology and Hypertension
Erlangen University
Erlangen, Germany

Salt sensitivity as a predisposing factor for nephrosclerosis and diabetic nephropathy

The structural cardiac effects of salt loading: beyond blood pressure elevation

Prof Paolo Ferrari
Dept. Nephrology
Fremantle Hospital
Perth, Australia

Dr Javier Diez
Department of Cardiology
University Clinic
Pamplona, Spain

The future of Transplantation, novel treatments of APKD, cardiovascular risk and the Mediterranean diet

	Inducing transplant tolerance: progress and challenges		Update in Xenotransplantation
Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy		Dr. E. Cozzi Department of Medical and Surgical Sciences University of Padua Padua, Italy

	New treatment options for ADPKD (results from ongoing clinical trials)		A hypothesis generating exercise on cardiovascular risk in ESRD: secondary analyses of the 4D study
Prof G. Walz Renal Division University Hospital Freiburg Freiburg, Germany		Prof C.Wanner Bayerische-Julius-Maximilans University Department of Medicine, Division of Nephrology Würzburg, Germany

	Building on Greek heritage: Mediterranean Diet for a healthy long life
Prof A. Trichopoulou Department of Hygiene and Epidemiology University of Athens Medical School Athens, Greece

Revised European Best Practice Guideline for Haemodialysis DOWNLOAD HERE

Haemodynamic instability during haemodialysis

Vascular access

Dr Jeroen P. Kooman
Department of Internal Medicine
Division of Nephrology
University Hospital Maastricht
Maastricht, The Netherlands

Dr Jan Tordoir
Department of Surgery
University Hospital Maastricht
Maastricht, The Netherlands

Protein and energy malnutrition

Dialysis strategies

Dr Denis Fouque
Department of Nephrology
Hospital Edouard Herriot
University Lyon 1
Lyon, France

Dr James Tattersall
Department of Renal Medicine
St. James's University Hospital
Leeds, United Kingdom

	The preparation and conduct of clinical studies		How to assess study quality?
Dr. K.J. Jager ERA-EDTA Registry - Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands		Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy

	Interaction and effect modification
Dr. F.W. Dekker Dept. Clinical Epidemiology Leiden University Medical Center Leiden, The Netherlands

	Adipokines in End-Stage Renal Disease - fat tissue send nephrologists a message		Triiodothyronine in ESRD: a key player in inflammation and malnutrition or an innocent bystander?
Dr P. Stenvinkel Dept of Renal Medicine K56 Huddinge University Hospital Karolinska Institutet Stockholm, Sweden		Dr F. Mallamaci Nephrology, Dialysis, Transplantation and Hypertension Unit, OO.RR and CNR Istituto di Biomedicina, Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy

	Exploring the complexity of inflammation and cardiovascular risk in ESRD by a global approach including proteomic evaluation
Prof Z. Massy Nephrology and Clinical Pharmacology Departments, University Hospital of Amiens, Amiens, France

	Removal of nephrotoxic free light chains by haemodialysis		Myeloma kidney: towards novel therapies. New insights from in vitro and in vivo models of renal injury
Dr A.R. Bradwell IDRL, Department of Immunology The Medical School, University of Birmingham Birmingham, United Kingdom		Dr V. Batuman Section of Nephrology Tulane University Medical School New Orleans, LO, USA

	AL-Amyloidosis and other light chain deposition diseases: novel treatment perspectives
Dr A. Jaccard Department of Hematology, Centre Hospitalier Universitaire Université et Centre National de la Recherche Scientifique, UMR 6101 Limoges, France

Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney

Antibody blockade of tnf-alpha in experimental crescentic glomerulonephritis

Dr H.P. Marti
Division of Nephrology and Hypertension
University of Bern
Bern, Switzerland

Dr C.D. Pusey
Faculty of Medicine
Imperial College
London, United Kingdom

Nf-kb as a target to treat glomerulonephritis

Pi3 kinase inhibitors as therapeutic agents in experimental lupus nephritis

Dr A. Amore
Chief of the Pediatric Dialysis Unit
Regina Margherita Hospital
Turin, Italy

Dr A.C. Carrera
Department of Immunology and Oncology
Centro Nacional de Biotecnología/CSIC
Madrid, Spain

	Renovascular disease imaging. The potential of new noninvasive methods: MR perfusion imaging		Renovascular disease screening in high-risk populations: interactions of cardiologist and nephrologist
Dr Philip Kalra Department of Renal Medicine Hope Hospital Salford, United Kingdom		Prof J. Mann Dept. of Nephrology and Hypertension Schwabing General Hospital LMU Munich, Germany

	Getting to the “heart of the matter” - combatting high cardiovascular risk in renovascular disease
Dr David J A Goldsmith Renal Unit Guy's Hospital London, United Kingdom

Innate immunity stimuli, toll like receptors and renal glomerulonephritis

Transcriptional control mechanism in human glomerular diseases

Dr H.-J. Anders
Ludwig-Maximilians-Universitaet
Med. Poliklinik, Klinikum Innenstadt
Munich, Germany

Prof M. Kretzler
Div. Nephrology - Dept. Internal Medicine
Univ. Michigan Medical Center - 1560 MSRB II
Ann Arbor, MI, USA

Investigating alloimmunization in glomerular diseases

Countering adma as a new pathway for retarding renal disease progression

Prof P. Ronco
INSERM Unit 702, University Pierre and Marie Curie
Tenon Hospital
Paris, France

Dr S. Ueda
Division of Nephrology, Department of Medicine
Kurume University School of Medicine
Kurume, Japan

	Innate immunity in IGA nephropathy		Genetic susceptibility to IgAN and genetic risk factors for progression in IgAN
Prof R. Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy		Prof F.P. Schena Head of the Nephrology, Dyalisis and Transplant Unit of Bari University Bari, Italy

	Complement in innate immunity and in IgAN		Is tonsillectomy an effective therapeutic option in IgAN?
Prof M.R. Daha Dept of Nephrology Leiden University Medical Center Leiden, The Netherlands		Prof J. Feehally Dept of Nephrology Leicester General Hospital Leicester, United Kingdom


	Deciphering the role of C-Reactive Protein in human diseases		Implementation of EPB guidelines concerning haemodialysis dose quantification: how far are we?
Prof M. Pepys Centre for Amyloidosis and Acute Phase Proteins Royal Free and University College Medical School London, United Kingdom		Dr C. Couchoud Agence de la biomédecine REIN Registry Saint-Denis-La-Plaine, France

	How can we improve our ERA-EDTA coding systems and definitions to increase comparability between renal registry data?
Dr K. Simpson Renal Unit Royal Infirmary Glasgow, United Kingdom

Premature vascular senescence in renal disease: Methuselah’s dilemma

Mechanism(s) of renal fibrosis: can it be reverted?

Dr M.S. Goligorsky
Renal Research Institute and Division of Nephrology
New York Medical College
Valhalla, NY, USA

Dr C. Chatziantoniou
Inserm U.702
Hopital Tenon
Paris, France

Treatment of acute renal failure by administration of bone marrow-derived mesenchymal stromal cells

Dr C. Lange
Center of Bone Marrow Transplantation
University Hospital Hamburg-Eppendorf
Hamburg, Germany

How to search for the best evidence in clinical practice

How to search for the best evidence in clinical practice

Dr G. Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine
Cochrane Renal Group, School of Public Health
University of Sydney
Sidney, Australia

Prof J. Galle
Director Department of Nephrology and Dialysis
Hospital Clinic Lüdenscheid
Lüdenscheid, Germany

Orchestrating kidney development

Intrarenal inflammation and oxidative stress as a common final pathway in salt-sensitive hypertension

Prof A. Woolf
Nephro-Urology Unit
UCL Institute of Child Health
London, United Kingdom

Prof B. Rodriguez-Iturbe
Hospital Universitario de Maracaibo
Centro de Investigaciones Biomedicas
Maracaibo, Venezuela